Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print LIAI scientists make major finding on potential cure for type 1 diabetes

LIAI scientists make major finding on potential cure for type 1 diabetes

April 21, 2006

Human clinical trials planned to begin later this year

SAN DIEGO - A major finding, which represents an important step toward a potential cure for type 1 (insulin-dependent) diabetes, has been made by a research team at the La Jolla Institute for Allergy & Immunology (LIAI). The team, led by Matthias von Herrath, M.D., an internationally recognized expert on the molecular basis of type 1 diabetes, used a combinatorial treatment approach in laboratory mice and found it reversed recent onset type 1 diabetes in the majority of animals tested.




The study, which combined two therapies (anti-CD3 antibody and proinsulin peptide) already being tested individually in human clinical trials, produced better efficacy, longer-lasting results and fewer side effects in the preclinical trials in mice than either therapy has shown alone in the human studies. The researchers hope to begin testing the combination therapy in human clinical trials later this year. Damien Bresson, a researcher in Dr. von Herrath's lab, contributed to the study. Kevan Herold, an Associate professor at Columbia University, and Jeffrey Bluestone, Director of the University of California, San Francisco Diabetes Center, were also contributors.

"The finding of increased efficacy of reversal of recent-onset type 1 diabetes in animals that received a combination of systemic anti-CD3 antibody and intranasal proinsulin peptide compared to therapy with the antibody alone is an exciting and important finding," said Richard A. Insel, M.D., Executive Vice President for Research at the Juvenile Diabetes Research Foundation.

The anti-CD3 antibody has been shown to temporarily reverse recent onset human type 1 diabetes in two independent clinical trials. The reversal was maintained for more than a year. "This combination approach is worth evaluating in human type 1 diabetes to increase both the overall efficacy of the treatment and the duration of the beneficial effect," Dr. Insel said.

The finding was published today in the online version of the Journal of Clinical Investigation in a paper, "A novel combination therapy in recent onset autoimmune diabetes: synergy of anti-CD3 and nasal proinsulin to induce Tregs." Dr. von Herrath said the human clinical trials, which still require regulatory approval, would be directed at persons recently diagnosed with type 1 diabetes or who are already being treated for pre-diabetes.

George Eisenbarth, M.D., Ph.D., Executive Director of the Barbara Davis Center for Childhood Diabetes in Colorado, called the finding "a very important discovery, demonstrating synergistic efficacy of two therapies (anti-CD3 and proinsulin immunomodulation) that are in human studies for the prevention of type 1 diabetes."

Dr. von Herrath's approach focuses on teaching the immune system to tolerate, rather than attack, the insulin-producing beta cells of the pancreas. By injecting the anti-CD3 antibody, which calms the immune system and lessens the attack on the beta cells, along with a piece of the nasal proinsulin peptide, which acts like a vaccine and induces a special cell type called "regulatory cells" that can actively and highly specifically protect beta cells, Dr. von Herrath was able to stop the immune system's destruction of the beta cells in mice.

Combining the two therapies produced a "strong synergy," he said. "The combinatorial approach doubled the efficacy in laboratory mice - with fewer side effects than using either one alone." The study represented the first time a combinatorial treatment approach using a vaccine strategy had ever been tried in type 1 diabetes. Dr. von Herrath added that the combined therapy also showed long-lasting results. "The diabetes never reoccurred in the lifespan of the mice."

Mitchell Kronenberg, Ph.D, LIAI President and Scientific Director, said the therapy is "particularly attractive because - if successful in humans - it could replace current insulin-injection treatments altogether, which often cannot prevent the long-term detrimental effects of diabetes." Type 1 diabetes, also called insulin-dependent diabetes or juvenile diabetes, occurs when the immune system mistakenly destroys the insulin-producing beta cells of the pancreas, which are key to controlling blood sugar levels. As a result, type 1 diabetes sufferers inject insulin daily to control blood sugar levels. However, complete control is difficult to achieve and damage to body organ systems can still occur. Complications from type 1 diabetes can include kidney failure, adult blindness and the need for amputations.

"Since the complications from high blood sugar levels (diabetes) worsen with time, we are hopeful that this therapy can reverse the disease in patients before they have too much multi-organ damage," Dr. von Herrath said.

La Jolla Institute for Allergy and Immunology



Related Type 1 Diabetes Current Events and Type 1 Diabetes News Articles Type 1 Diabetes Current Events and Type 1 Diabetes News RSS Type 1 Diabetes Current Events and Type 1 Diabetes News RSS
UM Scientists Create Fruit Fly Model to Help Unravel Genetics of Human Diabetes
As rates of obesity, diabetes, and related disorders have reached epidemic proportions in the US in recent years, scientists are working from many angles to pinpoint the causes and contributing factors involved in this public health crisis.

Vegetables can protect unborn child against diabetes
New evidence is emerging for how important it is for pregnant women to eat good, nutritious food. Expecting mothers who eat vegetables every day seem to have children who are less likely to develop type 1 diabetes, a new study from the Sahlgrenska Academy has revealed.

Protein critical for insulin secretion may be contributor to diabetes
A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.

Diabetic Episodes Affect Kids' Memory
Children who have had an episode of diabetic ketoacidosis, a common complication of diabetes, may have persistent memory problems, according to a new study from researchers at the UC Davis Center for Mind and Brain.

A major step in making better stem cells from adult tissue
October 15, 2009 A team led by scientists from The Scripps Research Institute has developed a method that dramatically improves the efficiency of creating stem cells from human adult tissue, without the use of embryonic cells.

Blood counts are clues to human disease
A new genome-wide association study published today in Nature Genetics begins to uncover the basis of genetic variations in eight blood measurements and the impact those variants can have on common human diseases.

Self-monitoring of blood glucose
Diabetes patients should always control their own blood sugar values if this leads to improvements in their treatment.

Is inhaled insulin delivery still a possibility? Why has it been a commercial failure?
The commercial failure of Exubera® (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market.

Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards -- the 2009 NIH Director's Pioneer Award.

JDRF-funded studies show regular CGM use increases diabetes control for all age groups
The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors - six days per week or more - rather than the age of patients, and that benefits continue well past the time when people with type 1 diabetes begin using the devices - including experiencing fewer low blood sugar emergencies.
More Type 1 Diabetes Current Events and Type 1 Diabetes News Articles
Type 1 Diabetes For Dummies (For Dummies (Health & Fitness))

Type 1 Diabetes For Dummies (For Dummies (Health & Fitness))
by Alan L. Rubin MD (Author)

Whether you have been living with type 1 diabetes for some time, or you have just discovered that your child is diabetic, there’s a lot you need to know about the new developments in treating, controlling, and living with this disease. Type 1 Diabetes For Dummies, explains everything you need to know and do to make living with type 1 diabetes easier and healthier.

This reassuring, plain-English guide helps you understand and mange the disease with tips on working with your doctor, administering insulin, developing a diet an exercise plan, and coping with illness and travel. You’ll find out about the latest technologies of blood glucose monitoring and insulin delivery, and get a handle on everything you need to do to keep yourself or your child healthy, active, and feeling...

Type 1 Diabetes: A Guide for Children, Adolescents, Young Adults--and Their Caregivers, Third Edition

Type 1 Diabetes: A Guide for Children, Adolescents, Young Adults--and Their Caregivers, Third Edition
by M.D. Ragnar Hanas M.D. (Author), Ph.D. Stuart Brink Ph.D. (Foreword), Jeff Hitchcock (Foreword)

Living with type 1 diabetes requires intensive, nonstop daily management, week after week, year after year. This means that young people with type 1 and their parents have to become experts on their own condition—even better informed than the average doctor—and able to self-manage its daily demands. The Type 1 Diabetes Book is the most authoritative book ever published on the condition and will become the one book that every young person with type 1 diabetes will need to own. "In this book," writes author Dr. Ragnar Hanas, "I speak directly, all the time, to you, the person with diabetes. The topics covered range from how your body works to sweets, treats, and ice cream; from insulin injection technique to long-term complications; and any number of subjects in between. With this book...

Medical Management of Type 1 Diabetes

Medical Management of Type 1 Diabetes
by American Diabetes Association (ADA) (Author)

Featuring a recommended course of diagnosing and treating patients with type 1 diabetes

A comprehensive resource for health care professionals that outlines the American Diabetes Association’s recommended course of diagnosing and treating patients with type 1 diabetes. This comprehensive volume provides the basis for individualized, flexible, responsive treatment plans for patients with type 1 diabetes. It includes integrated approaches on blood pressure and lipid goals, proper nutrition, exercise, smoking cessation, and more. All based on the clinical practice recommendations of the American Diabetes Association.

A Field Guide to Type 1 Diabetes

A Field Guide to Type 1 Diabetes
by American Diabetes Association (Author)

Living with diabetes is as challenging as hiking and camping in the wilderness.

As it always pays to be prepared before beginning a journey, it also pays for people with diabetes to be prepared before they start each day. In true Field Guide fashion, this book boils down vital information for readers into short sections and checklists of their necessities, what they need to do, and what to take with them on the course of their day. A Field Guide to Type 1 Diabetes includes sections on insulin; tools, food, and exercise; complications; and how to's.

Key features include: Background on the biology and physical aspects of type 1 diabetes Vital information about insulin, insulin plans, and delivery methods Easy-to-understand charts and checklists that walk readers through...

Insulin Pump Therapy Demystified: An Essential Guide for Everyone Pumping Insulin (Marlowe Diabetes Library)

Insulin Pump Therapy Demystified: An Essential Guide for Everyone Pumping Insulin (Marlowe Diabetes Library)
by Gabrielle Kaplan-Mayer (Author), M.S. Gary Scheiner M.S. (Foreword)

Increasing numbers of people with type 1 diabetes, all of whose lives depend on insulin, as well as type 2 diabetics, have already adopted the insulin pump, which replaces a regimen of insulin shots with a continuous delivery of insulin. Yet many who stand to benefit from "the pump" are put off by not fully understanding the device, and many already using it don’t have anyone with whom to compare notes about its use. Now Gabrielle Kaplan-Mayer, who has used the pump for more than three years, cuts through common personal fears about the pump and offers insight into the day-to-day challenges—and rewards—of life with it. Drawing on interviews with more than seventy-five pump users, including Nicole Johnson, Miss America 1999, as well as diabetes experts and other health professionals,...

Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin

Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin
by M.S. Gary Scheiner M.S. (Author), Ph.D. Barry Goldstein M.D. M.D. (Foreword)

Dozens of books offer advice on managing diabetes, but few focus specifically on the day-to-day issues facing those who use insulin. Now Gary Scheiner, a certified diabetes educator and himself an insulin user himself since 1985, gives you the tools to "think like a pancreas"--that is, to successfully master the art and science of matching insulin to the body’s ever-changing needs. Free of medical mumbo jumbo, comprehensive, and packed with useful information not readily available in other books, Think Like a Pancreas discusses:

• day-to-day blood glucose control and monitoring
• designing an insulin program to best match your lifestyle
• measuring insulin to carbohydrate intake and physical activity
• the pluses and minuses of different insulin-delivery...

Ampalaya: Nature's Remedy for Type 1 And Type 2 Diabetes

Ampalaya: Nature's Remedy for Type 1 And Type 2 Diabetes
by Frank Murray (Author)

Diabetes mellitus--the fifth leading cause of death in the United States--increased alarmingly in 1999, prompting the government to call the disease an unfolding epidemic. By 2025,it is estimated there will be 22 million Americans with diabetes. As this book details, diabetes can often be prevented or controlled with positive lifestyle changes, including the use of ampalaya (aka bitter melon), a vegetable that is being used around the world as a tea, in capsules, or in its whole form to successfully lower blood sugar levels in diabetics. The vegetable itself is also tasty and beneficial. This book will teach you everything you need to know to put ampalaya to work for you.

WeeklyTrack Diabetes Management Kit (The Complete Diabetes Self-Management Log Book)

WeeklyTrack Diabetes Management Kit (The Complete Diabetes Self-Management Log Book)
by OSS Publishing Company (Author)

Improve your diabetes self-management! This easy-to-use diabetes log book covers all aspects of diabetes self-care for Type 1 or Type 2 diabetics, whether using oral medications (pills), insulin injections, or an insulin pump. No more chasing separate pieces of paper and fumbling with tiny booklets!WeeklyTrack Diabetes Management Kit keeps all of your detailed diabetes information in one book, but still shows you the "big picture" of your diabetes management. Each WeeklyTrack book holds one full year of information. Unlike other systems, there are no refills or extras to buy. One book per year is all you need. It's not a calendar -- start when you want, fill in your own dates. Designed by a diabetic, WeeklyTrack provides daily diabetes logging with color-coded charts in a unique...

Appraise Hemoglobin A1C Home Test Kit

Appraise Hemoglobin A1C Home Test Kit
by Appraise

INDICATIONS: Appraise diabetes A1c home test kit, 90462. Clinically accurate information you can use with your Healthcare provider to assess your daibetes treatment plan.

No Added Sugar - growing up with type 1 diabetes

No Added Sugar - growing up with type 1 diabetes
by Fibi Ward (Author)

Fibi Ward, now 14, writes: 'At the time I was diagnosed [aged 13], I wanted to read something written by somebody of my own age, from their perspective, about how they dealt with being diagnosed, and to reassure myself that all the fears and worries that I had were normal. However,I have not seen any such book on the market and have decided to record my own experiences so that other children and teenagers who are newly diagnosed with type 1 diabetes can get some benefit and comfort by reading about and relating to them.'

According to Diabetes UK, 10,000 to 15,000 people in the UK are diagnosed with type 1 diabetes every year. The peak age of diagnosis is between 10 and 14 years. Coming so early in life, such a diagnosis can feel like a life sentence, both for the young person and for...

© 2009 BrightSurf.com